David Estapé, a long-time biotechnology expert who holds a doctorate in chemical engineering and has 22 years of experience, will join CRB Group as  Technology Manager Biotechnology and will be based in Basel, Switzerland.

Currently Technology Manager Life Sciences at M+W Group, an international plant engineering firm, Estapé has worked on major biotech projects globally, driven biotech strategy internally, gained experience in GMP and facility design for biopharma, and participated heavily in organizations like the International Society for Pharmaceutical Engineering (ISPE), BioPhorum Operations Group and Parenteral Drug Association. 

Estapé studied Chemical Engineering at the Autonomous University of Barcelona (UAB) and received his degree in 1989. After an Erasmus exchange study at the Technical University Delft (NL) he did his PhD research at the GBF (Gesellschaft für Biotechnologische Forschung) in Braunschweig, Germany. In 1996 he received his PhD degree from the UAB and joined Life Sciences Meissner + Wurst (LSMW), a German life sciences solutions provider that later became part of M+W Group. Starting as junior engineer, in his 22-year career at M+W Estapé held various positions and eventually became Technology Manager in the global business unit Life Sciences and Chemicals.

Estapé’s major focus at CRB will be to provide CRB’s clients with expertise in biotechnology front-end engineering, process technologies, regulatory/Good Manufacturing Practice, advanced facility design and strategic planning. While he will be based in Basel, Estapé will be available to support all 15 of CRB’s offices and enhance CRB’s existing capabilities in the biotechnology market.